NLRP3 and liver dysplastic nodule: Recent studies underscore the ability of the Nrf2/HO-1 signaling pathway to inhibit NLRP3 inflammatory vesicle activation, thereby attenuating podocyte injury and improving DN-related renal function and histopathology (31).